Suppr超能文献

女性罕见的 21-羟化酶缺陷症单纯男性化型、格雷夫斯病和 47,XXX 并存:病例报告。

Rare combination of simple virilizing form of 21-hydroxylase deficiency, Graves' disease and 47, XXX in a woman: A case report.

机构信息

Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, China.

Department of Pharmacology, Shanxi Medical University, Taiyuan, China.

出版信息

Medicine (Baltimore). 2022 Oct 28;101(43):e31443. doi: 10.1097/MD.0000000000031443.

Abstract

RATIONALE

Coexistence of congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Graves' disease and 47, XXX is rare. We report a case of a 25-year-old woman presented with masculine appearance, hirsutism and enlarged clitoris. Lab tests showed elevated serum 17 hydroxyprogesterone, testosterone, dehydroepiandrosterone. Gene test revealed heterozygous gene mutation in CYP21A2:NM_000500:exon4:c.518 T > A, NM_000500:exon8:c.C1024T. Karyotype analysis showed 47, XXX. After prednisone replacement and antithyroid therapy, she got a normal menstruation and normal level of testosterone. These findings demonstrate that patients with abnormal chromosome are likely to combine 21-hydroxylase deficiency (21-OHD), thus karyotyping test should not be neglected for those who have been already diagnosed as 21-OHD. Additionally, chromosomal abnormality such as 47, XXX and Turner syndrome had susceptibility to develop autoimmune thyroid disease because a gene on X chromosome may be responsible for the occurrence of autoimmune thyroid disease. Moreover, both 21-OHD and Graves' disease (GD) can lead to high level of testosterone, thus we should keep in mind to test chromosome and thyroid function in 21-OHD patients to avoid misdiagnose or missed diagnosis. To the best of our knowledge, this is the first report of simple virilizing (SV) 21-OHD patient combined with 47, XXX and Graves disease.

PATIENT CONCERNS

A 24-years-old female of Han ethnicity was admitted to the endocrinology department complaining of absence of menses for half a year. The patient didn't noticed her enlarged clitoris until she was 17 years old. Her menarche was 16 years old and the final height was 163 centimeter. She was diagnosed with GD 2 months before admission to our hospital due to palpitation, heat intolerance, muscle weakness.

DIAGNOSES

The patient was diagnosed with SV 21-OHD, Graves disease and 47, XXX.

INTERVENTIONS

At first, the patient was given 10 mg methimazole twice a day as well as 5 mg predisone in the morning and 2.5 mg in the evening. After a year of regular medication and reexamination, she got a regular menstruation and thyroid function and now is taking 2.5 mg prednisone twice a day.

OUTCOMES

The patient got a regular menstruation and thyroid function. Laboratory results showed: testosterone declined to 0.1nmol/L (0.1-1.67nmol/L) and 17 hydroxyprogesterone get back to normal level: 1.01ng/ml (0.30-2.34ng/mL). However, her enlarged clitoris has not narrowed.

LESSONS

Patients with abnormal chromosome are likely to combine 21-OHD, thus karyotyping test should not be neglected for those who have been already diagnosed as 21-OHD. Additionally, chromosomal abnormality such as 47, XXX and Turner syndrome had susceptibility to develop autoimmune thyroid disease because a gene on X chromosome may be responsible for the occurrence of autoimmune thyroid disease. Moreover, both 21-OHD and GD can lead to high level of testosterone, thus we should keep in mind to test chromosome and thyroid function in 21-OHD patients to avoid misdiagnose or missed diagnosis. To the best of our knowledge, this is the first report of SV 21-OHD patient combined with 47, XXX and Graves disease.

摘要

背景

21-羟化酶缺陷导致的先天性肾上腺皮质增生症、格雷夫斯病和 47,XXX 同时存在的情况较为罕见。我们报告了一例 25 岁女性,表现为男性化外观、多毛症和阴蒂增大。实验室检查显示血清 17-羟孕酮、睾酮、脱氢表雄酮升高。基因检测显示 CYP21A2 基因杂合突变:NM_000500:exon4:c.518T> A,NM_000500:exon8:c.C1024T。染色体核型分析显示 47,XXX。经泼尼松替代和抗甲状腺治疗后,患者月经恢复正常,睾酮水平正常。这些发现表明,染色体异常的患者可能合并 21-羟化酶缺陷(21-OHD),因此对于已经诊断为 21-OHD 的患者,不应忽视染色体核型检查。此外,X 染色体上的一个基因可能与自身免疫性甲状腺疾病的发生有关,因此像 47,XXX 和特纳综合征这样的染色体异常也易发生自身免疫性甲状腺疾病。此外,21-OHD 和格雷夫斯病(GD)均可导致睾酮水平升高,因此我们应牢记在 21-OHD 患者中检测染色体和甲状腺功能,以避免误诊或漏诊。据我们所知,这是首例单纯性男性化(SV)21-OHD 患者合并 47,XXX 和格雷夫斯病的报告。

患者关注

一名 24 岁汉族女性因闭经半年到内分泌科就诊。患者直到 17 岁才发现自己的阴蒂增大。她的初潮年龄为 16 岁,最终身高为 163 厘米。2 个月前因心悸、怕热、肌无力被诊断为 GD。

诊断

患者被诊断为 SV 21-OHD、GD 和 47,XXX。

干预措施

起初,患者每天服用 10mg 甲巯咪唑两次,并在早上和晚上各服用 5mg 和 2.5mg 泼尼松。经过一年的规律用药和复查,患者恢复了正常的月经和甲状腺功能,现在每天服用 2.5mg 泼尼松两次。

结果

患者月经恢复正常,甲状腺功能正常。实验室结果显示:睾酮降至 0.1nmol/L(0.1-1.67nmol/L),17-羟孕酮恢复正常水平:1.01ng/ml(0.30-2.34ng/mL)。然而,她的阴蒂没有缩小。

经验教训

染色体异常的患者可能合并 21-OHD,因此对于已经诊断为 21-OHD 的患者,不应忽视染色体核型检查。此外,像 47,XXX 和特纳综合征这样的染色体异常也易发生自身免疫性甲状腺疾病,因为 X 染色体上的一个基因可能与自身免疫性甲状腺疾病的发生有关。此外,21-OHD 和 GD 均可导致睾酮水平升高,因此我们应牢记在 21-OHD 患者中检测染色体和甲状腺功能,以避免误诊或漏诊。据我们所知,这是首例 SV 21-OHD 患者合并 47,XXX 和格雷夫斯病的报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ef2/9622681/a11090a3704b/medi-101-e31443-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验